Skip to content

Multidimensional analysis of the effectiveness of stellate ganglion block in patients with insomnia disorders

Multidimensional analysis of the effectiveness of stellate ganglion block in patients with insomnia disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099219
Enrollment
Unknown
Registered
2025-03-19
Start date
2025-03-21
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

Sponsors

The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years old, gender is not limited; 2. Meet the diagnostic criteria for insomnia in the Chinese Guidelines for the Diagnosis and Treatment of Insomnia in Adults (2017 Edition), that is, the presence of one or more of the symptoms of difficulty falling asleep (sleep onset latency >30 minutes), sleep maintenance disorder (awakening >= 2 times throughout the night), early awakening, decreased sleep quality, and decreased total sleep time (usually less than 6.5 hours), and occur at least 3 times a week for more than 3 months; 3. Signed informed consent with the patient or his/her family;

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiovascular and cerebrovascular diseases (such as acute myocardial infarction, unstable angina, severe arrhythmia, stroke, etc.), liver and kidney insufficiency, endocrine system diseases (such as hyperthyroidism or hypothyroidism, etc.), severe physical diseases; 2. Those who are allergic to local anesthetics; 3. Patients with abnormal coagulation function and infection at the puncture site; 4. Patients with cognitive dysfunction and cognitive dysfunction; 5. Those who have poor compliance and are unable to complete the study content and information collection;

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
Patient health questionnaire-9;Generalized anxiety disorder-7;Psychomotor vigilance task;Heart rate variability;

Countries

China

Contacts

Public ContactWang Shuangrui

The Third Affiliated Hospital of Guangzhou University of Chinese Medicine

wsr05155@126.com+86 17860691569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 7, 2026